688117 聖諾生物
按盤價 
29.790 -0.660 (-2.167%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 6.333 | 8.243 | 8.001 | 10.019 | 14.741 |
| 總資產報酬率 ROA (%) | 4.005 | 5.804 | 6.247 | 7.906 | 10.792 |
| 投入資產回報率 ROIC (%) | 4.506 | 6.684 | 7.241 | 9.527 | 14.461 | 邊際利潤分析 |
| 銷售毛利率 (%) | 58.992 | 63.761 | 65.470 | 71.973 | 79.207 |
| 營業利潤率 (%) | 19.057 | 18.643 | 18.407 | 19.613 | 18.425 |
| 息稅前利潤/營業總收入 (%) | 21.021 | 19.547 | 17.896 | 17.758 | 17.844 |
| 淨利潤/營業總收入 (%) | 16.818 | 16.166 | 16.296 | 15.847 | 15.840 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 102.976 | 96.783 | 101.844 | 98.751 | 96.433 |
| 價值變動淨收益/利潤總額(%) | 0.976 | -1.774 | 3.407 | 2.078 | 0.000 |
| 營業外收支淨額/利潤總額(%) | -0.722 | -1.223 | -0.659 | -7.551 | -1.317 | 償債能力分析 |
| 流動比率 (X) | 1.394 | 2.525 | 2.960 | 4.013 | 2.318 |
| 速動比率 (X) | 0.847 | 1.720 | 2.358 | 3.389 | 1.697 |
| 資產負債率 (%) | 39.881 | 33.109 | 25.385 | 17.926 | 26.208 |
| 帶息債務/全部投入資本 (%) | 32.713 | 23.452 | 11.966 | 4.619 | 1.177 |
| 股東權益/帶息債務 (%) | 204.760 | 324.497 | 728.473 | 2,041.479 | 8,202.879 |
| 股東權益/負債合計 (%) | 150.740 | 201.990 | 293.929 | 457.857 | 281.560 |
| 利息保障倍數 (X) | 10.010 | 17.315 | -45.787 | -37.140 | -52.257 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 83.528 | 86.151 | 92.325 | 92.768 | 85.100 |
| 存貨周轉天數 (天) | 438.551 | 376.514 | 311.938 | 317.967 | 403.420 |
| 備註： | 即時報價更新時間為 15/11/2024 16:29 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
